References
- Agius G, Dindinaud G, Biggar RJ, Peyre R, Vaillant V, Ranger S, Poupet JY, Cisse MF, Castets M. (1990) An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings. J. Med. Viral. 30, 117-127. https://doi.org/10.1002/jmv.1890300208
- Chanock RM, Finberg L. (1957) Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiological aspects of infection in infants and young children. Am. J. Hyg. 66, 291-300.
- Englund JA, Sullivian CJ, Jordan MC et aI. (1988) Respiratory syncytial virus infection in immunocompromised adults. Amm. Int. Med. 109, 203-208. https://doi.org/10.7326/0003-4819-109-3-203
- Falsey AR, Cunningham CK, Barker WH, Kouides RW, Yuen JB, Menegus M, Weiner LB, Bonville CA, Betts RF. (1995) Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J. Infect. Dis. 172, 389-394. https://doi.org/10.1093/infdis/172.2.389
- Fleming DM, Cross KW. (1993) Respiratory syncytial virus or influenza. Lancet 342,1507-1510. https://doi.org/10.1016/S0140-6736(05)80082-0
- Gardner PS. (1973) Respiratory syncytial virus infections. Postgrad. Med. J. 49, 788-791. https://doi.org/10.1136/pgmj.49.577.788
- Glezen WP, Denny FW. (1973) Epidemiology of acute lower respiratory disease in children. New Engl. J. Med. 11, 239-243.
- Groothuis JR, Gutierrez KM, Lauer BA (1988) Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 82, 199-203.
- Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus Sun SC et al. (1986) Respiratory syncytial virus infection in children with compromised immune function. N. Engl. J. Med. 315, 77-81. https://doi.org/10.1056/NEJM198607103150201
- Harrington RD, Hooton TM, Hackman RC et al. (1992) An outbreak of respiratory syncytial virus in bone transplant center. J. Infect. Dis. 165, 987-993. https://doi.org/10.1093/infdis/165.6.987
- Hebert MF, Guglielmo BJ. (1990) What is the clinical role of aerosolized Ribavirin. DICP 24, 735-738. https://doi.org/10.1177/106002809002400717
- Hruska JF, Morrow PE, Suffin SC, Douglas RG. (1982) In vivo inhibition of respiratory syncytial virus by Ribavirin. Antimicrob. Agents Chemother. 21, 125-130. https://doi.org/10.1128/AAC.21.1.125
- Kazufuumi Kimura, Shuichi Mori, Kiyoko Tomita et al. (2000) Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo. Antiviral research 47, 41-51. https://doi.org/10.1016/S0166-3542(00)00091-7
- Kim HW, Arroyo JO. (1973) Epidemiology of respiratory syncytial virus in Washington, DC. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am. J. Epidemiol. 98, 216-225. https://doi.org/10.1093/oxfordjournals.aje.a121550
- Liu Mifeng et al. (2001) The anti-respiratory syncytial virus effect of a Chinese medical herb-No.1 in HeLa culture. Heilongjiang med. J. 14, 266-268.
- MacDonald NE, Hall CB, Sun SC, Alexson C, Harris PJ, Manning JA. (1982) Respiratory syncytial virus infection in infants with congenital heart disease. N. Engl. J. Med. 307, 397-400. https://doi.org/10.1056/NEJM198208123070702
- Martin AJ, Gardner PS, McQuillin J. (1978) Epidemiology of respiratory viral infection among pediatric inpatients over a six year period in northeast England. Lancet 2, 1035-1038.
- Martin CJ, Kneyber . Henriette A. Moll . Ronald de Groot. (2000) Treatment and prevention of respiratory syncytial virus infection. Eur. J. Pediatr. 159, 399-411. https://doi.org/10.1007/s004310051296
- Medical Research Council Subcommittee on Respiratory Syncytial Virus Vaccines. (1978) Respiratory syncytial virus infection: admissions to hospital in industrial, urban, and rural areas. Br. Med. J. 2, 796-798. https://doi.org/10.1136/bmj.2.6140.796
- Michael G, Ison a, John Mills b, Peter Openshaw. (2002) Current research on respiratory viral infections: Fourth International Symposium. Antiviral Research 55,227-278. https://doi.org/10.1016/S0166-3542(02)00055-4
- Reed LJ, Muench H. (1938) AA simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 495-497.